the scientific and medical network
the scientific and medical network Company Information
Company Number
04544694
Next Accounts
Sep 2025
Shareholders
-
Group Structure
View All
Industry
Other education n.e.c.
Registered Address
52 fore street, callington, PL17 7AJ
the scientific and medical network Estimated Valuation
Pomanda estimates the enterprise value of THE SCIENTIFIC AND MEDICAL NETWORK at £303.5k based on a Turnover of £435.9k and 0.7x industry multiple (adjusted for size and gross margin).
the scientific and medical network Estimated Valuation
Pomanda estimates the enterprise value of THE SCIENTIFIC AND MEDICAL NETWORK at £358.4k based on an EBITDA of £89.2k and a 4.02x industry multiple (adjusted for size and gross margin).
the scientific and medical network Estimated Valuation
Pomanda estimates the enterprise value of THE SCIENTIFIC AND MEDICAL NETWORK at £302.4k based on Net Assets of £126.8k and 2.38x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Scientific And Medical Network Overview
The Scientific And Medical Network is a live company located in callington, PL17 7AJ with a Companies House number of 04544694. It operates in the other education n.e.c. sector, SIC Code 85590. Founded in September 2002, it's largest shareholder is unknown. The Scientific And Medical Network is a mature, micro sized company, Pomanda has estimated its turnover at £435.9k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Scientific And Medical Network Health Check
Pomanda's financial health check has awarded The Scientific And Medical Network a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
3 Weak
Size
annual sales of £435.9k, make it in line with the average company (£497.5k)
£435.9k - The Scientific And Medical Network
£497.5k - Industry AVG
Growth
3 year (CAGR) sales growth of 38%, show it is growing at a faster rate (6.4%)
38% - The Scientific And Medical Network
6.4% - Industry AVG
Production
with a gross margin of 56.8%, this company has a comparable cost of product (56.8%)
56.8% - The Scientific And Medical Network
56.8% - Industry AVG
Profitability
an operating margin of 18.5% make it more profitable than the average company (4.7%)
18.5% - The Scientific And Medical Network
4.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (12)
1 - The Scientific And Medical Network
12 - Industry AVG
Pay Structure
on an average salary of £50.8k, the company has a higher pay structure (£29.5k)
£50.8k - The Scientific And Medical Network
£29.5k - Industry AVG
Efficiency
resulting in sales per employee of £435.9k, this is more efficient (£54k)
£435.9k - The Scientific And Medical Network
£54k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - The Scientific And Medical Network
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - The Scientific And Medical Network
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - The Scientific And Medical Network
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 137 weeks, this is more cash available to meet short term requirements (111 weeks)
137 weeks - The Scientific And Medical Network
111 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 37.6%, this is a higher level of debt than the average (24.6%)
37.6% - The Scientific And Medical Network
24.6% - Industry AVG
THE SCIENTIFIC AND MEDICAL NETWORK financials
The Scientific And Medical Network's latest turnover from December 2023 is £435.9 thousand and the company has net assets of £126.8 thousand. According to their latest financial statements, The Scientific And Medical Network has 1 employee and maintains cash reserves of £201.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 435,894 | 276,291 | 336,781 | 164,210 | 291,674 | 314,615 | 199,219 | 169,272 | 178,037 | 184,734 | 234,389 | 267,237 | 238,058 | 194,649 | 292,924 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | 66,915 | -23,866 | 76,092 | -38,331 | 35,280 | 22,900 | 259 | -14,503 | 4,209 | -6,291 | -14,556 | 2,519 | 849 | -30,295 | 8,471 |
| Tax | |||||||||||||||
| Profit After Tax | 66,915 | -23,866 | 76,092 | -38,331 | 35,280 | 22,900 | 259 | -14,503 | 4,209 | -6,291 | -14,556 | 2,519 | 849 | -30,295 | 8,471 |
| Dividends Paid | |||||||||||||||
| Retained Profit | 66,915 | -23,866 | 76,092 | -38,331 | 35,280 | 22,900 | 259 | -14,503 | 4,209 | -6,291 | -14,556 | 2,519 | 849 | -30,295 | 8,471 |
| Employee Costs | 50,826 | 46,634 | 34,978 | 29,136 | 29,548 | 24,728 | 24,358 | 22,613 | 25,108 | 51,661 | 55,832 | 55,096 | 51,640 | 51,607 | 52,401 |
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 227 | 307 | 714 | 1,178 | 443 | 152 | 1 | 363 | 549 | 826 | 703 | 93 | 593 | ||
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 227 | 307 | 714 | 1,178 | 443 | 152 | 1 | 363 | 549 | 826 | 703 | 93 | 593 | ||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 159 | 1,529 | |||||||||||||
| Group Debtors | |||||||||||||||
| Misc Debtors | 1,356 | 2,111 | 700 | 25,000 | 26,000 | 12,000 | 15,487 | 39,814 | 5,780 | 2,642 | 3,259 | 5,634 | 6,052 | 6,182 | |
| Cash | 201,680 | 119,229 | 142,158 | 66,874 | 64,752 | 62,516 | 29,665 | 69,839 | 10,332 | 48,602 | 55,826 | 69,736 | 61,926 | 56,908 | 102,141 |
| misc current assets | |||||||||||||||
| total current assets | 203,036 | 121,340 | 142,158 | 67,733 | 91,281 | 88,516 | 41,665 | 85,326 | 50,146 | 54,382 | 58,468 | 72,995 | 67,560 | 62,960 | 108,323 |
| total assets | 203,263 | 121,647 | 142,872 | 68,911 | 91,724 | 88,668 | 41,666 | 85,689 | 50,695 | 55,208 | 59,171 | 72,995 | 67,560 | 63,053 | 108,916 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 5,500 | ||||||||||||||
| Group/Directors Accounts | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 76,484 | 61,783 | 31,295 | 33,426 | 17,908 | 50,132 | 26,030 | 70,312 | 20,815 | 29,537 | 26,209 | 25,477 | 22,561 | 18,903 | 28,971 |
| total current liabilities | 76,484 | 61,783 | 31,295 | 33,426 | 17,908 | 50,132 | 26,030 | 70,312 | 20,815 | 29,537 | 27,209 | 26,477 | 23,561 | 19,903 | 35,471 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 76,484 | 61,783 | 31,295 | 33,426 | 17,908 | 50,132 | 26,030 | 70,312 | 20,815 | 29,537 | 27,209 | 26,477 | 23,561 | 19,903 | 35,471 |
| net assets | 126,779 | 59,864 | 111,577 | 35,485 | 73,816 | 38,536 | 15,636 | 15,377 | 29,880 | 25,671 | 31,962 | 46,518 | 43,999 | 43,150 | 73,445 |
| total shareholders funds | 126,779 | 59,864 | 111,577 | 35,485 | 73,816 | 38,536 | 15,636 | 15,377 | 29,880 | 25,671 | 31,962 | 46,518 | 43,999 | 43,150 | 73,445 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 342 | 414 | 464 | 464 | 163 | 50 | 1,171 | 308 | 277 | 277 | 250 | 94 | 500 | 200 | |
| Amortisation | 8,048 | 13,829 | |||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | -755 | 2,111 | -859 | -25,670 | 529 | 14,000 | -3,487 | -24,327 | 34,034 | 3,138 | -617 | -2,375 | -418 | -130 | 6,182 |
| Creditors | -5,500 | 5,500 | |||||||||||||
| Accruals and Deferred Income | 14,701 | 30,488 | -2,131 | 15,518 | -32,224 | 24,102 | -44,282 | 49,497 | -8,722 | 3,328 | 732 | 2,916 | 3,658 | -10,068 | 28,971 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -201 | -809 | -122 | -390 | |||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | -201 | -809 | -122 | -390 | |||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -1,000 | 1,000 | |||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | -27,847 | -1,000 | 65,974 | ||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 82,451 | -22,929 | 75,284 | 2,122 | 2,236 | 32,851 | -40,174 | 59,507 | -38,270 | -7,224 | -13,910 | 7,810 | 5,018 | -45,233 | 102,141 |
| overdraft | |||||||||||||||
| change in cash | 82,451 | -22,929 | 75,284 | 2,122 | 2,236 | 32,851 | -40,174 | 59,507 | -38,270 | -7,224 | -13,910 | 7,810 | 5,018 | -45,233 | 102,141 |
the scientific and medical network Credit Report and Business Information
The Scientific And Medical Network Competitor Analysis
Perform a competitor analysis for the scientific and medical network by selecting its closest rivals, whether from the EDUCATION sector, other micro companies, companies in PL17 area or any other competitors across 12 key performance metrics.
the scientific and medical network Ownership
THE SCIENTIFIC AND MEDICAL NETWORK group structure
The Scientific And Medical Network has no subsidiary companies.
Ultimate parent company
THE SCIENTIFIC AND MEDICAL NETWORK
04544694
the scientific and medical network directors
The Scientific And Medical Network currently has 6 directors. The longest serving directors include Ms Jaqueline Nielsen (Jul 2005) and Mr Tuvi Orbach (Nov 2013).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Jaqueline Nielsen | England | 75 years | Jul 2005 | - | Director |
| Mr Tuvi Orbach | England | 76 years | Nov 2013 | - | Director |
| Dr Joan Walton | England | 72 years | May 2017 | - | Director |
| Ms Laurel Waterman | England | 43 years | Feb 2024 | - | Director |
| Mr Simon Duan | England | 62 years | May 2024 | - | Director |
| Dr Filippo Dal Fiore | England | 47 years | Sep 2024 | - | Director |
P&L
December 2023turnover
435.9k
+58%
operating profit
80.8k
0%
gross margin
56.8%
+1.82%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
126.8k
+1.12%
total assets
203.3k
+0.67%
cash
201.7k
+0.69%
net assets
Total assets minus all liabilities
the scientific and medical network company details
company number
04544694
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
85590 - Other education n.e.c.
incorporation date
September 2002
age
23
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
ANDREW M FARR
auditor
-
address
52 fore street, callington, PL17 7AJ
Bank
BARCLAYS BANK PLC
Legal Advisor
-
the scientific and medical network Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the scientific and medical network.
the scientific and medical network Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE SCIENTIFIC AND MEDICAL NETWORK. This can take several minutes, an email will notify you when this has completed.
the scientific and medical network Companies House Filings - See Documents
| date | description | view/download |
|---|
